Ariel Investments’s AbbVie ABBV Stock Holding History

Ariel Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-84,394	Closed	-$17.7M	–	105
2025 Q1	$17.7M	Sell	84,394 -67,358	-44%	-$13.1M	0.21%	77
2024 Q4	$27M	Buy	+151,752	New	+$27.9M	0.29%	75

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ariel Investments's ABBV Position: Q2 2025 in Review

Ariel Investments sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 84,394 shares — an estimated $17.7M sold.

Ariel Investments first reported a position in ABBV in Q4 2024 and held it in 2 quarters. The position peaked at $27M in Q4 2024. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Ariel Investments reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
Ariel Investments sold 84,394 AbbVie shares in Q2 2025, an estimated $17.7M.
Ariel Investments first reported a position in AbbVie in Q4 2024 and held it in 2 quarters.
Ariel Investments's AbbVie position peaked at $27M in Q4 2024.
3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Ariel Investments's 13F filing for Q2 2025, filed 14 Aug 2025.